Skip to main content

Table 1 Features and demographic of CCM patients and healthy subjects

From: Elevated proportion of TLR2- and TLR4-expressing Th17-like cells and activated memory B cells was associated with clinical activity of cerebral cavernous malformations

Characteristics

CCM patients

Health non-CCM subjects

Symptomatic

Asymptomatic

Bleeding

Epilepsy

  

Sample size, N (%)

20 (55%)

3 (8%)a

14 (37%)

20

Age, years (mean)

44

38

48

40.1

Female, N (%)

12 (60%)

3 (100%)

10 (71%)

10 (50%)

Sporadic, N (%)

17 (85%)

3 (100%)

7 (50%)

NAc

Familiar, N (%)

3 (15%)

0

7 (50%)

NA

DVA, N (%)b

8 (40%)

1 (33%)

3 (21%)

NA

Ethnicity

 Caucasian. N (%)

18 (88%)

2 (66%)

9 (66%)

14 (70%)

 African-Brazilian, N (%)

2 (12%)

1 (34%)

5 (34%)

6 (30%)

  1. aTwo from three patients with epilepsy were using Oxcarbazepine (Trileptal) to control seizure crises. The subjects, patients and healthy individuals recruited, were not taking any medication at the time of blood sampling. bDevelopmental venous anomaly. cNot applicable